Last updated on January 2020

Factor VIII Gene Therapy Study in Patients With Hemophilia A

Brief description of study

The purpose of this study is to determine the safety and tolerability of the factor VIII gene transfer treatment with BAY 2599023 (DTX201) in individuals with severe hemophilia A.

Clinical Study Identifier: NCT03588299

Find a site near you

Start Over